Henry Schein (NASDAQ:HSIC) rose 7.4% amid a report that an activist investor has taken a stake and is pushing for the dental ...

Henry Schein (NASDAQ:HSIC) advanced 5.3% following a 3.3% increase on Friday amid some speculation the dental products ...

Activist investor Ananym Capital Management is urging healthcare products distributor Henry Schein to refresh its board, cut costs, tackle succession planning and consider selling its medical ...

Dental care supplier Henry Schein advanced in Monday trading as investors bet that Robert F. Kennedy Jr., President-elect ...

Dental care supplier Henry Schein advanced in Monday trading as investors bet that Robert F. Kennedy Jr., President-elect ...

The most recent earnings report from Henry Schein, Inc. (NASDAQ:HSIC) was disappointing for shareholders. However, our analysis suggests that the soft headline numbers are getting counterbalanced by ...

Henry Schein Inc. closed $12.62 short of its 52-week high ($82.63), which the company reached on February 27th.

The 12-month price targets, analyzed by analysts, offer insights with an average target of $79.5, a high estimate of $82.00, ...

Henry Schein (HSIC – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Michael ...

Analyst Erin Wright of Morgan Stanley maintained a Sell rating on Henry Schein (HSIC – Research Report), retaining the price target of ...

Despite modest sales growth, Henry Schein Inc (HSIC) boosts EPS guidance and expands its global e-commerce platform.